Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
DSP Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesCipla Limited8.72521790481278.3482
Domestic EquitiesSun Pharmaceutical Industries Limited8.21531535592262.0795
Domestic EquitiesIPCA Laboratories Limited7.83761696381250.0296
Domestic EquitiesCohance Lifesciences Limited7.79172489539248.5680
Domestic EquitiesLaurus Labs Limited6.07872217884193.9207
Domestic EquitiesGland Pharma Limited5.9590920673190.1006
Domestic EquitiesApollo Hospitals Enterprise Limited4.5777194767146.0363
Domestic EquitiesAlembic Pharmaceuticals Limited4.37791428180139.6617
Domestic EquitiesSai Life Sciences Limited4.31581703020137.6807
Domestic EquitiesPfizer Limited3.2671200644104.2245
Domestic EquitiesKovai Medical Center and Hospital Limited3.2343165156103.1804
Domestic EquitiesIndoco Remedies Limited3.22173233474102.7760
Domestic EquitiesVijaya Diagnostic Centre Limited3.1527935530100.5742
Domestic EquitiesProcter & Gamble Health Limited2.943715928893.9082
Domestic EquitiesConcord Biotech Limited2.713348977486.5578
Domestic EquitiesEmcure Pharmaceuticals Limited1.737839328955.4380
Domestic EquitiesUnichem Laboratories Limited1.665285206353.1219
Domestic EquitiesICICI Lombard General Insurance Company Limited1.458224141346.5203
Domestic EquitiesAarti Drugs Limited1.353685215543.1830
Domestic EquitiesThyrocare Technologies Limited0.952022906430.3716
Domestic EquitiesAlkem Laboratories Limited0.58883733418.7831
Domestic EquitiesMedplus Health Services Limited0.560319207817.8738
Domestic EquitiesJupiter Life Line Hospitals Limited0.42199411713.4587
Domestic EquitiesLaxmi Dental Limited0.371028040111.8343
Total 85.5206 2728.2311
Cash & Cash Equivalents and Net AssetsTREPS / Reverse Repo Investments1.8973 60.5265
Cash & Cash Equivalents and Net AssetsNet Receivables/Payables-0.0601 -1.9170
Total 1.8372 58.6095
Overseas EquitiesIllumina Inc4.5217160400144.2490
Overseas EquitiesGlobus Medical Inc3.8828268800123.8678
Overseas EquitiesIntuitive Surgical Inc2.47821876879.0570
Overseas EquitiesAbbott Laboratories1.09453160034.9147
Overseas EquitiesGrail Inc0.082087332.6158
Total 12.0591 384.7043
Overseas Mutual Fund UnitsGlobal X Funds - Global X Genomics & Biotechnology ETF0.583124500018.6016
Total 0.5831 18.6016
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.